{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:24Z","timestamp":1786982244935,"version":"build-2736575974"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12072-023-10590-1","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:01:57Z","timestamp":1695906117000},"page":"1333-1349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["How non-alcoholic fatty liver disease and cirrhosis affect the heart"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-7764","authenticated-orcid":false,"given":"S\u00f8ren","family":"M\u00f8ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Barl\u00f8se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"10590_CR1","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S M\u00f8ller","year":"2013","unstructured":"M\u00f8ller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804\u20132811","journal-title":"Eur Heart J"},{"key":"10590_CR2","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.3748\/wjg.v20.i42.15492","volume":"20","author":"N Gassanov","year":"2014","unstructured":"Gassanov N, Caglayan E, Semmo N, Massenkeil G, Er F. Cirrhotic cardiomyopathy: a cardiologist\u2019s perspective. World J Gastroenterol. 2014;20:15492\u201315498","journal-title":"World J Gastroenterol"},{"key":"10590_CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2020","unstructured":"Arroyo V, Angeli P, Moreau R, Jalan R, Claria J, Trebicka J, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2020;74:670\u2013685","journal-title":"J Hepatol"},{"key":"10590_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2012.03.032","volume":"79","author":"A Krag","year":"2012","unstructured":"Krag A, Bendtsen F, Burroughs AK, M\u00f8ller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012;79:53\u201355","journal-title":"Med Hypotheses"},{"key":"10590_CR5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","volume":"35","author":"S Raevens","year":"2015","unstructured":"Raevens S, Geerts A, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Colle I. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int. 2015;35:1646\u20131660","journal-title":"Liver Int"},{"key":"10590_CR6","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s10620-015-3752-3","volume":"60","author":"S M\u00f8ller","year":"2015","unstructured":"M\u00f8ller S, Bendtsen F. Cirrhotic multiorgan syndrome. Dig Dis Sci. 2015;60:3209\u20133225","journal-title":"Dig Dis Sci"},{"key":"10590_CR7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","volume":"38","author":"S M\u00f8ller","year":"2018","unstructured":"M\u00f8ller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38:570\u2013580","journal-title":"Liver Int"},{"key":"10590_CR8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jhep.2018.04.026","volume":"69","author":"E Alvarado","year":"2018","unstructured":"Alvarado E, Garcia-Guix M, Mirabet S, Villanueva C. The relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis. J Hepatol. 2018;69:746\u2013747","journal-title":"J Hepatol"},{"key":"10590_CR9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/liv.14433","volume":"40","author":"M Praktiknjo","year":"2020","unstructured":"Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, et al. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int. 2020;40:1457\u20131466","journal-title":"Liver Int"},{"key":"10590_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8278(00)80582-6","volume":"32","author":"A Perello","year":"2000","unstructured":"Perello A, Inserte J, Godoy A, Puigfel Y, Garcia-Pagan JC, Garcia-Dorado D, et al. Cardiac structure and function in experimental intra-hepatic portal hypertension. J Hepatol. 2000;32:65","journal-title":"J Hepatol"},{"key":"10590_CR11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","volume":"58","author":"K Hallsworth","year":"2012","unstructured":"Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, Macgowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol. 2012;58:757\u2013762","journal-title":"J Hepatol"},{"key":"10590_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","volume":"15","author":"QM Anstee","year":"2018","unstructured":"Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425\u2013439","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10590_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.30040","volume":"68","author":"M Izzy","year":"2018","unstructured":"Izzy M, Oh J, Watt KD. Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander. Hepatology. 2018;68:10","journal-title":"Hepatology"},{"key":"10590_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/17474124.2019.1587293","volume":"13","author":"S M\u00f8ller","year":"2019","unstructured":"M\u00f8ller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol. 2019;13:10","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10590_CR15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/MCG.0000000000000323","volume":"49","author":"MH Wehmeyer","year":"2015","unstructured":"Wehmeyer MH, Heuer AJ, Benten D, Puschel K, Sydow K, Lohse AW, et al. High rate of cardiac abnormalities in a postmortem analysis of patients suffering from Liver cirrhosis. J Clin Gastroenterol. 2015;49:866\u2013872","journal-title":"J Clin Gastroenterol"},{"key":"10590_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2017.08.001","volume":"22","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Henry L, Bush H, Mishra A. Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22:1\u201310","journal-title":"Clin Liver Dis"},{"key":"10590_CR17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.15679","volume":"51","author":"R Loomba","year":"2020","unstructured":"Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51:1149\u20131159","journal-title":"Aliment Pharmacol Ther"},{"key":"10590_CR18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69:1691\u20131705","journal-title":"Gut"},{"key":"10590_CR19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014279","volume":"9","author":"LB Vanwagner","year":"2020","unstructured":"Vanwagner LB, Wilcox JE, Ning H, Lewis CE, Carr JJ, Rinella ME, et al. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: The CARDIA Study. J Am Heart Assoc. 2020;9: e014279","journal-title":"J Am Heart Assoc"},{"key":"10590_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00125-019-05024-3","volume":"63","author":"MCGJ Brouwers","year":"2020","unstructured":"Brouwers MCGJ, Simons N, Stehouwer CDA, Isaacs A. Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. Diabetologia. 2020;63:253\u2013260","journal-title":"Diabetologia"},{"key":"10590_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/radiol.2020201057","volume":"297","author":"A Isaak","year":"2020","unstructured":"Isaak A, Praktiknjo M, Jansen C, Faron A, Sprinkart AM, Pieper CC, et al. Myocardial fibrosis and inflammation in liver cirrhosis: MRI Study of the liver-heart axis. Radiology. 2020;297:51\u201361","journal-title":"Radiology"},{"key":"10590_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0000000000000845","volume":"33","author":"DB Njoku","year":"2022","unstructured":"Njoku DB, Schilling JD, Finck BN. Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver-heart crosstalk. Curr Opin Lipidol. 2022;33:295\u2013299","journal-title":"Curr Opin Lipidol"},{"key":"10590_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-017-9827-9","volume":"12","author":"J Bosch","year":"2018","unstructured":"Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1\u201310","journal-title":"Hepatol Int"},{"key":"10590_CR24","volume":"3","author":"Y Iwakiri","year":"2021","unstructured":"Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep. 2021;3: 100316","journal-title":"JHEP Rep"},{"issue":"Suppl 1","key":"10590_CR25","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Cl\u00e0ria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49-s66","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10590_CR26","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jhep.2020.12.005","volume":"75","author":"T Gustot","year":"2021","unstructured":"Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol. 2021;75(Suppl 1):S36-s48","journal-title":"J Hepatol"},{"key":"10590_CR27","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/liv.13394","volume":"37","author":"A Voiosu","year":"2017","unstructured":"Voiosu A, Wiese S, Voiosu T, Bendtsen F, M\u00f8ller S. Bile acids and cardiovascular function in cirrhosis. Liver Int. 2017;37:1420\u20131430","journal-title":"Liver Int"},{"key":"10590_CR28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","volume":"1864","author":"T Vasavan","year":"2018","unstructured":"Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik J, Williamson C. Heart and bile acids\u2014clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1345\u20131355","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10590_CR29","doi-asserted-by":"crossref","first-page":"114388","DOI":"10.1016\/j.ab.2021.114388","volume":"636","author":"MS Desai","year":"2021","unstructured":"Desai MS. Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy. Anal Biochem. 2021;636:114388","journal-title":"Anal Biochem"},{"key":"10590_CR30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","volume":"71","author":"M Sorribas","year":"2019","unstructured":"Sorribas M, Jakob MO, Yilmaz B, Li H, Stutz D, Noser Y, et al. FxR-modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J Hepatol. 2019;71:1126\u20131140","journal-title":"J Hepatol"},{"key":"10590_CR31","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/hep.23918","volume":"52","author":"P Bellot","year":"2010","unstructured":"Bellot P, Garcia-Pagan JC, Frances R, Abraldes JG, Navasa M, Perez-Mateo M, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology. 2010;52:2044\u20132052","journal-title":"Hepatology"},{"key":"10590_CR32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hepr.13473","volume":"50","author":"JP Arab","year":"2020","unstructured":"Arab JP, Arrese M, Shah VH. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: current concepts and perspectives. Hepatol Res. 2020;50:407\u2013418","journal-title":"Hepatol Res"},{"key":"10590_CR33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72:558\u2013577","journal-title":"J Hepatol"},{"key":"10590_CR34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12072-017-9784-3","volume":"11","author":"V Arroyo","year":"2017","unstructured":"Arroyo V. Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome. Hepatol Int. 2017;11:242\u2013244","journal-title":"Hepatol Int"},{"key":"10590_CR35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2018.02.007","volume":"68","author":"MJ Coenraad","year":"2018","unstructured":"Coenraad MJ, Porcher R, Bendtsen F. Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango. J Hepatol. 2018;68:887\u2013889","journal-title":"J Hepatol"},{"key":"10590_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","volume":"15","author":"M Bernardi","year":"2018","unstructured":"Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018;15:753\u2013764","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10590_CR37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","volume":"68","author":"L Turco","year":"2018","unstructured":"Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Caporali C, et al. Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis. J Hepatol. 2018;68:949\u2013958","journal-title":"J Hepatol"},{"key":"10590_CR38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archinte.1958.00030010405009","volume":"102","author":"JH Lunseth","year":"1958","unstructured":"Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med. 1958;102:405\u2013413","journal-title":"AMA Arch Intern Med"},{"key":"10590_CR39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-2277.2011.01219.x","volume":"24","author":"FH Saner","year":"2011","unstructured":"Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, et al. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24:425\u2013432","journal-title":"Transpl Int"},{"key":"10590_CR40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2022.102369","volume":"89","author":"S Ben Hammouda","year":"2022","unstructured":"Ben Hammouda S, Grayaa M, Njima M, Mabrouk S, Boussaid M, Aissaoui A, et al. Sudden death due to cirrhotic cardiomyopathy: an autopsy case report. J Forensic Leg Med. 2022;89: 102369","journal-title":"J Forensic Leg Med"},{"key":"10590_CR41","first-page":"126","volume":"4","author":"CL Jellis","year":"2014","unstructured":"Jellis CL, Kwon DH. Myocardial T1 mapping: modalities and clinical applications. Cardiovasc Diagn Ther. 2014;4:126\u2013137","journal-title":"Cardiovasc Diagn Ther"},{"key":"10590_CR42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2011.02.030","volume":"55","author":"TK Glenn","year":"2011","unstructured":"Glenn TK, Honar H, Liu H, Keurs H, Lee SS. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol. 2011;55:1249\u20131255","journal-title":"J Hepatol"},{"key":"10590_CR43","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1111\/liv.14599","volume":"40","author":"H Honar","year":"2020","unstructured":"Honar H, Liu H, Zhang ML, Glenn TK, Ter Keurs HEDJ, Lee SS. Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy. Liver Int. 2020;40:2808\u20132819","journal-title":"Liver Int"},{"key":"10590_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOG.0000000000000733","volume":"37","author":"H Liu","year":"2021","unstructured":"Liu H, Yoon KT, Zhang J, Lee SS. Advances in cirrhotic cardiomyopathy. Curr Opin Gastroenterol. 2021;37:187\u2013193","journal-title":"Curr Opin Gastroenterol"},{"key":"10590_CR45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.29520","volume":"68","author":"M Cesari","year":"2018","unstructured":"Cesari M, Frigo AC, Tonon M, Angeli P. Cardiovascular predictors of death in patients with cirrhosis. Hepatology. 2018;68:215\u2013223","journal-title":"Hepatology"},{"key":"10590_CR46","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s10554-020-01920-7","volume":"36","author":"S Wiese","year":"2020","unstructured":"Wiese S, Liang M, Mo S, Bendtsen F, Hove JD, M\u00f8ller S. Left atrial volume changes assessed by real time 3-dimensional echocardiography in relation to liver function and prognosis in patients with cirrhosis. Int J Cardiovasc Imaging. 2020;36:2121\u20132127","journal-title":"Int J Cardiovasc Imaging"},{"key":"10590_CR47","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0016-5085(88)80092-1","volume":"95","author":"WGJ Rector","year":"1988","unstructured":"Rector WGJ, Hossack KF. Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished \u201ceffective\u201d arterial blood volume? Gastroenterology. 1988;95:1658\u20131663","journal-title":"Gastroenterology"},{"key":"10590_CR48","first-page":"472","volume":"22","author":"S M\u00f8ller","year":"1995","unstructured":"M\u00f8ller S, S\u00f8ndergaard L, M\u00f8gelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology. 1995;22:472\u2013478","journal-title":"Hepatology"},{"key":"10590_CR49","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0016-5085(92)90192-2","volume":"102","author":"FW Lewis","year":"1992","unstructured":"Lewis FW, Adair O, Rector WG. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology. 1992;102:1024\u20131029","journal-title":"Gastroenterology"},{"key":"10590_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs0970259","volume":"97","author":"F Wong","year":"1999","unstructured":"Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci. 1999;97:259\u2013267","journal-title":"Clin Sci"},{"key":"10590_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs0970259","volume":"97","author":"F Wong","year":"1999","unstructured":"Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci (Lond). 1999;97:259\u2013267","journal-title":"Clin Sci (Lond)"},{"key":"10590_CR52","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1111\/j.1572-0241.2000.03252.x","volume":"95","author":"V Valeriano","year":"2000","unstructured":"Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol. 2000;95:3200\u20133205","journal-title":"Am J Gastroenterol"},{"key":"10590_CR53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","volume":"49","author":"F Wong","year":"2001","unstructured":"Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001;49:268\u2013275","journal-title":"Gut"},{"key":"10590_CR54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejim.2014.01.011","volume":"25","author":"F Sampaio","year":"2014","unstructured":"Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, et al. Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis. Eur J Intern Med. 2014;25:246","journal-title":"Eur J Intern Med"},{"key":"10590_CR55","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","volume":"58","author":"L Ruiz-Del-Arbol","year":"2013","unstructured":"Ruiz-Del-Arbol L, Achecar L, Serradilla R, Rodriguez-Gandia MA, Rivero M, Garrido E, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine. Hepatology. 2013;58:1732\u20131742","journal-title":"Hepatology"},{"key":"10590_CR56","doi-asserted-by":"crossref","first-page":"G253","DOI":"10.1152\/ajpgi.00402.2018","volume":"317","author":"S Wiese","year":"2019","unstructured":"Wiese S, Hove JD, Mo S, Mygind ND, Tonnesen J, Petersen CL, et al. Cardiac dysfunction in cirrhosis: a 2-year longitudinal follow-up study using advanced cardiac imaging. Am J Physiol Gastrointest Liver Physiol. 2019;317:G253\u2013G263","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10590_CR57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/liv.13287","volume":"37","author":"M Merli","year":"2017","unstructured":"Merli M, Torromeo C, Giusto M, Iacovone G, Riggio O, Puddu PE. Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass. Liver Int. 2017;37:700\u2013706","journal-title":"Liver Int"},{"key":"10590_CR58","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1097\/TP.0000000000002025","volume":"102","author":"L Puchades","year":"2018","unstructured":"Puchades L, Chau S, Dodson JA, Mohamad Y, Mustain R, Lebsack A, et al. Association of cardiac abnormalities to the frail phenotype in cirrhotic patients on the waitlist: From the functional assessment in liver transplantation study. Transplantation. 2018;102:e101\u2013e107","journal-title":"Transplantation"},{"key":"10590_CR59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jum.14516","volume":"37","author":"N Gunay","year":"2018","unstructured":"Gunay N, Erdem S, Guvenc TS, Bulur A, Ozdil K, Hasdemir H, et al. Morphologic and functional changes in right-sided cardiac chambers in patients with chronic liver disease and normal pulmonary artery pressure. J Ultrasound Med. 2018;37:1681\u20131691","journal-title":"J Ultrasound Med"},{"key":"10590_CR60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31544-3","volume":"10","author":"NX Ortiz-Olvera","year":"2011","unstructured":"Ortiz-Olvera NX, Castellanos-Pallares G, G\u00f3mez-Jim\u00e9nez LM, Cabrera-Mu\u00f1oz ML, M\u00e9ndez-Navarro J, Mor\u00e1n-Villota S, et al. Anatomical cardiac alterations in liver cirrhosis: an autopsy study. Ann Hepatol. 2011;10:321\u2013326","journal-title":"Ann Hepatol"},{"key":"10590_CR61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2459\/JCM.0b013e3280c7c29c","volume":"9","author":"M De Marco","year":"2008","unstructured":"De Marco M, Chinali M, Romano C, Benincasa M, D\u2019Addeo G, D\u2019Agostino L, et al. Increased left ventricular mass in pre-liver transplantation cirrhotic patients. J Cardiovasc Med (Hagerstown). 2008;9:142\u2013146","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10590_CR62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCIMAGING.113.000722","volume":"7","author":"R Yotti","year":"2014","unstructured":"Yotti R, Bermejo J, Benito Y, Sanz-Ruiz R, Ripoll C, Martinez-Legazpi P, et al. Validation of noninvasive indices of global systolic function in patients with normal and abnormal loading conditions: a simultaneous echocardiography pressure-volume catheterization study. Circ Cardiovasc Imaging. 2014;7:164\u2013172","journal-title":"Circ Cardiovasc Imaging"},{"key":"10590_CR63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","volume":"58","author":"A Nazar","year":"2013","unstructured":"Nazar A, Guevara M, Sitges M, Terra C, Sola E, Guigou C, et al. Left ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction. J Hepatol. 2013;58:51\u201357","journal-title":"J Hepatol"},{"key":"10590_CR64","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/hep.23585","volume":"51","author":"MS Desai","year":"2010","unstructured":"Desai MS, Shabier Z, Taylor M, Lam F, Thevananther S, Kosters A, et al. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology. 2010;51:2097\u20132107","journal-title":"Hepatology"},{"key":"10590_CR65","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","volume":"52","author":"JH Henriksen","year":"2003","unstructured":"Henriksen JH, G\u00f8etze JP, Fuglsang S, Christensen E, Bendtsen F, M\u00f8ller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis Relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52:1511\u20131517","journal-title":"Gut"},{"key":"10590_CR66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apt.15812","volume":"52","author":"S Wiese","year":"2020","unstructured":"Wiese S, Voiosu A, Hove JD, Danielsen KV, Voiosu T, Gr\u00c3,nbaek H, et al. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy. Aliment Pharmacol Ther. 2020;52:340\u2013350","journal-title":"Aliment Pharmacol Ther"},{"key":"10590_CR67","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/liv.13870","volume":"10","author":"S Wiese","year":"2018","unstructured":"Wiese S, Hove J, Mo S, Mookerjee RP, Petersen CL, Vester-Andersen MK, et al. Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome. Liver Int. 2018;10:1614\u20131623","journal-title":"Liver Int"},{"key":"10590_CR68","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v12.i6.837","volume":"12","author":"H Liu","year":"2006","unstructured":"Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol. 2006;12:837\u2013842","journal-title":"World J Gastroenterol"},{"key":"10590_CR69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10741-016-9552-9","volume":"21","author":"S M\u00f8ller","year":"2016","unstructured":"M\u00f8ller S, Wiese S, Halgreen H, Hove JD. Diastolic dysfunction in cirrhosis. Heart Fail Rev. 2016;21:599\u2013610","journal-title":"Heart Fail Rev"},{"key":"10590_CR70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cpf.12311","volume":"37","author":"S Wiese","year":"2017","unstructured":"Wiese S, Hove JD, Moller S. Cardiac imaging in patients with chronic liver disease. Clin Physiol Funct Imaging. 2017;37:347\u2013356","journal-title":"Clin Physiol Funct Imaging"},{"key":"10590_CR71","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/ehjci\/jeac235","volume":"24","author":"A Isaak","year":"2022","unstructured":"Isaak A, Chang J, Mesropyan N, Kravchenko D, Endler C, Bischoff L, et al. Cardiac involvement in non-cirrhotic portal hypertension: MRI detects myocardial fibrosis and oedema similar to compensated cirrhosis. Eur Heart J Cardiovasc Imaging. 2022;24:949\u2013960","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10590_CR72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijcard.2012.09.089","volume":"167","author":"S M\u00f8ller","year":"2013","unstructured":"M\u00f8ller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol. 2013;167:1101\u20131108","journal-title":"Int J Cardiol"},{"key":"10590_CR73","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/hep.31770","volume":"74","author":"S Raevens","year":"2021","unstructured":"Raevens S, Boret M, De Pauw M, Fallon MB, Van Vlierberghe H. Pulmonary abnormalities in liver disease: relevance to transplantation and outcome. Hepatology. 2021;74:1674\u20131686","journal-title":"Hepatology"},{"key":"10590_CR74","doi-asserted-by":"crossref","first-page":"388","DOI":"10.14309\/ajg.0000000000000462","volume":"115","author":"AN Koshy","year":"2020","unstructured":"Koshy AN, Farouque O, Cailes B, Testro A, Ramchand J, Sajeev JK, et al. Impaired cardiac reserve on dobutamine stress echocardiography predicts the development of hepatorenal syndrome. Am J Gastroenterol. 2020;115:388\u2013397","journal-title":"Am J Gastroenterol"},{"key":"10590_CR75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114388","volume":"636","author":"MS Desai","year":"2022","unstructured":"Desai MS. Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy. Anal Biochem. 2022;636: 114388","journal-title":"Anal Biochem"},{"key":"10590_CR76","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","volume":"22","author":"A Krag","year":"2010","unstructured":"Krag A, Bendtsen F, Mortensen C, Henriksen JH, M\u00f8ller S. Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol. 2010;22:1085\u20131092","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10590_CR77","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-015-0157-6","volume":"17","author":"F Sampaio","year":"2015","unstructured":"Sampaio F, Lamata P, Bettencourt N, Alt SC, Ferreira N, Kowallick JT, et al. Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy. J Cardiovasc Magn Reson. 2015;17:61\u20130157","journal-title":"J Cardiovasc Magn Reson"},{"key":"10590_CR78","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.14309\/ajg.0000000000001847","volume":"117","author":"KV Danielsen","year":"2022","unstructured":"Danielsen KV, Wiese S, Busk T, Nabilou P, Kronborg TM, Petersen CL, et al. Cardiovascular mapping in cirrhosis from the compensated stage to hepatorenal syndrome: a magnetic resonance Study. Am J Gastroenterol. 2022;117:1269\u20131278","journal-title":"Am J Gastroenterol"},{"key":"10590_CR79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MEG.0b013e32835d09fe","volume":"25","author":"TM Busk","year":"2013","unstructured":"Busk TM, Bendtsen F, M\u00f8ller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:523\u2013530","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10590_CR80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1572-0241.2002.05438.x","volume":"97","author":"M Merli","year":"2002","unstructured":"Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol. 2002;97:142\u2013148","journal-title":"Am J Gastroenterol"},{"key":"10590_CR81","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1478-3231.2011.02468.x","volume":"31","author":"K Kazankov","year":"2011","unstructured":"Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011;31:534\u2013540","journal-title":"Liver Int"},{"key":"10590_CR82","doi-asserted-by":"crossref","first-page":"E2616","DOI":"10.3390\/jcm9082616","volume":"9","author":"M Mechelinck","year":"2020","unstructured":"Mechelinck M, Hartmann B, Hamada S, Becker M, Andert A, Ulmer TF, et al. Global longitudinal strain at rest as an independent predictor of mortality in liver transplant candidates: a retrospective clinical study. J Clin Med. 2020;9:E2616","journal-title":"J Clin Med"},{"key":"10590_CR83","first-page":"345","volume":"71","author":"M Izzy","year":"2020","unstructured":"Izzy M, Vanwagner LB, Lin G, Altieri M, Findlay JY, Oh JK, et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology. 2020;71:345","journal-title":"Hepatology"},{"key":"10590_CR84","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/hep.32021","volume":"74","author":"H Liu","year":"2021","unstructured":"Liu H, Lee SS. Diagnostic criteria of cirrhotic cardiomyopathy: out with the old, in with the new? Hepatology. 2021;74:3523\u20133525","journal-title":"Hepatology"},{"key":"10590_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492791","volume":"9","author":"A Kazory","year":"2019","unstructured":"Kazory A, Ronco C. Hepatorenal syndrome or hepatocardiorenal syndrome: Revisiting basic concepts in view of emerging data. Cardiorenal Med. 2019;9:1\u20137","journal-title":"Cardiorenal Med"},{"key":"10590_CR86","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jhep.2018.05.037","volume":"69","author":"CR Bradley","year":"2018","unstructured":"Bradley CR, Cox EF, Scott RA, James MW, Kaye P, Aithal GP, et al. Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging. J Hepatol. 2018;69:1024","journal-title":"J Hepatol"},{"key":"10590_CR87","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the american society of echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321\u20131360","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10590_CR88","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.24768","volume":"23","author":"H Liu","year":"2017","unstructured":"Liu H, Jayakumar S, Traboulsi M, Lee SS. Cirrhotic cardiomyopathy: implications for liver transplantation. Liver Transpl. 2017;23:826\u2013835","journal-title":"Liver Transpl"},{"key":"10590_CR89","doi-asserted-by":"crossref","first-page":"475A","DOI":"10.1111\/j.1872-034X.2011.00794.x","volume":"54","author":"F Wong","year":"2011","unstructured":"Wong F, Villamil A, Merli M, Romero G, Angeli P, Caraceni P, et al. Prevalence of diastolic dysfunction in cirrhosis and its clinical significance. Hepatology. 2011;54:475A","journal-title":"Hepatology"},{"key":"10590_CR90","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12072-014-9544-6","volume":"8","author":"DS Karagiannakis","year":"2014","unstructured":"Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int. 2014;8:588\u2013594","journal-title":"Hepatol Int"},{"key":"10590_CR91","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","volume":"41","author":"M Razpotnik","year":"2021","unstructured":"Razpotnik M, Bota S, Wimmer P, Hackl M, Lesnik G, Alber H, et al. The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria. Liver Int. 2021;41:1058\u20131069","journal-title":"Liver Int"},{"key":"10590_CR92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.transproceed.2016.01.010","volume":"48","author":"F Carvalheiro","year":"2016","unstructured":"Carvalheiro F, Rodrigues C, Adrego T, Viana J, Vieira H, Seco C, et al. Diastolic dysfunction in liver cirrhosis: prognostic predictor in liver transplantation? Transplant Proc. 2016;48:128\u2013131","journal-title":"Transplant Proc"},{"key":"10590_CR93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cld.2021.01.012","volume":"25","author":"MJ Izzy","year":"2021","unstructured":"Izzy MJ, VanWagner LB. Current concepts of cirrhotic cardiomyopathy. Clin Liver Dis. 2021;25:471\u2013481","journal-title":"Clin Liver Dis"},{"key":"10590_CR94","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","volume":"314","author":"TM Busk","year":"2018","unstructured":"Busk TM, Bendtsen F, Poulsen JH, Clemmesen JO, Larsen FS, Goetze JP, et al. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2018;314:G275\u2013G286","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10590_CR95","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","volume":"56","author":"M Cazzaniga","year":"2007","unstructured":"Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869\u2013875","journal-title":"Gut"},{"key":"10590_CR96","first-page":"383","volume":"28","author":"M Shounak","year":"2015","unstructured":"Shounak M, Vimal R, Colin S, David IS. A retrospective analysis of the impact of diastolic dysfunction on one-year mortality after transjugular intrahepatic porto-systemic shunt, liver transplantation and non-transplant abdominal surgery in patients with cirrhosis. Ann Gastroenterol. 2015;28:383\u2013388","journal-title":"Ann Gastroenterol"},{"key":"10590_CR97","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/hep4.2062","volume":"6","author":"MC Meucci","year":"2022","unstructured":"Meucci MC, Hoogerduijn Strating MM, Butcher SC, van Rijswijk CSP, Van Hoek B, Delgado V, et al. Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt. Hepatol Commun. 2022;6:3163\u20133174","journal-title":"Hepatol Commun"},{"key":"10590_CR98","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/ajg.2009.321","volume":"104","author":"RN Rabie","year":"2009","unstructured":"Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E\/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2009;104:2458\u20132466","journal-title":"Am J Gastroenterol"},{"key":"10590_CR99","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jhep.2018.01.006","volume":"69","author":"S M\u00f8ller","year":"2018","unstructured":"M\u00f8ller S, Lee SS. Cirrhotic cardiomyopathy. J Hepatol. 2018;69:958\u2013960","journal-title":"J Hepatol"},{"key":"10590_CR100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.11.86","volume":"6","author":"M Bernardi","year":"2012","unstructured":"Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol. 2012;6:57\u201366","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10590_CR101","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/ajt.16500","volume":"21","author":"AN Koshy","year":"2021","unstructured":"Koshy AN, Gow PJ, Testro A, Teh AW, Ko J, Lim HS, et al. Relationship between QT-interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: a change in the current paradigm. Am J Transplant. 2021;21:2240\u20132245","journal-title":"Am J Transplant"},{"key":"10590_CR102","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jhep.2005.04.015","volume":"43","author":"H Ytting","year":"2005","unstructured":"Ytting H, Henriksen JH, Fuglsang S, Bendtsen F, M\u00f8ller S. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J Hepatol. 2005;43:637\u2013644","journal-title":"J Hepatol"},{"key":"10590_CR103","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00365510601182634","volume":"67","author":"JH Henriksen","year":"2007","unstructured":"Henriksen JH, Gulberg V, Fuglsang S, Schifter S, Bendtsen F, Gerbes AL, et al. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate. Scand J Clin Lab Invest. 2007;67:643\u2013653","journal-title":"Scand J Clin Lab Invest"},{"key":"10590_CR104","volume":"7","author":"WA Huang","year":"2018","unstructured":"Huang WA, Dunipace EA, Sorg JM, Vaseghi M. Liver disease as a predictor of new-onset atrial fibrillation. J Am Heart Assoc. 2018;7: e008703","journal-title":"J Am Heart Assoc"},{"key":"10590_CR105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.5009\/gnl210537","volume":"16","author":"W Lee","year":"2022","unstructured":"Lee W, Vandenberk B, Raj SR, Lee SS. Prolonged QT interval in cirrhosis: twisting time? Gut Liver. 2022;16:849\u2013860","journal-title":"Gut Liver"},{"key":"10590_CR106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/lt.22476","volume":"18","author":"W Rudzinski","year":"2012","unstructured":"Rudzinski W, Waller AH, Prasad A, Sood S, Gerula C, Samanta A, et al. New index for assessing the chronotropic response in patients with end-stage liver disease who are undergoing dobutamine stress echocardiography. Liver Transpl. 2012;18:355\u2013360","journal-title":"Liver Transpl"},{"key":"10590_CR107","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/lt.21495","volume":"14","author":"LG Umphrey","year":"2008","unstructured":"Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl. 2008;14:886\u2013892","journal-title":"Liver Transpl"},{"key":"10590_CR108","doi-asserted-by":"crossref","first-page":"G28","DOI":"10.1152\/ajpgi.2000.279.1.G28","volume":"279","author":"JH Zavecz","year":"2000","unstructured":"Zavecz JH, Bueno O, Maloney RE, ODonnell JM, Roerig SC, Battarbee HD. Cardiac excitation-contraction coupling in the portal hypertensive rat. Amer J Physiol Gastrointest L. 2000;279:G28\u2013G39","journal-title":"Amer J Physiol Gastrointest L"},{"key":"10590_CR109","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0168-8278(02)00010-7","volume":"36","author":"JH Henriksen","year":"2002","unstructured":"Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, M\u00f8ller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol. 2002;36:513\u2013520","journal-title":"J Hepatol"},{"key":"10590_CR110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/CRD.0000000000000379","volume":"30","author":"N Scalzo","year":"2022","unstructured":"Scalzo N, Canastar M, Lebovics E. Part 1: disease of the heart and liver: a relationship that cuts both ways. Cardiol Rev. 2022;30:111\u2013122","journal-title":"Cardiol Rev"},{"key":"10590_CR111","doi-asserted-by":"crossref","first-page":"H2966","DOI":"10.1152\/ajpheart.01227.2006","volume":"292","author":"S M\u00f8ller","year":"2007","unstructured":"M\u00f8ller S, Iversen JS, Henriksen JH, Bendtsen F. Reduced baroreflex sensitivity in alcoholic cirrhosis:relations to hemodynamics and humoral systems. Am J Physiol Heart Circ Physiol. 2007;292:H2966\u2013H2972","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10590_CR112","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0168-8278(09)60207-5","volume":"50","author":"S M\u00f8ller","year":"2009","unstructured":"M\u00f8ller S, Iversen JS, Krag A, Bendtsen F. Relation between baroreflex sensitivity and pulmonary dysfunction in cirrhosis: Effect of hyperoxia. J Hepatol. 2009;50:S84","journal-title":"J Hepatol"},{"key":"10590_CR113","doi-asserted-by":"crossref","first-page":"G330","DOI":"10.1152\/ajpgi.90488.2008","volume":"296","author":"AR Mani","year":"2008","unstructured":"Mani AR, Montagnese S, Jackson CD, Jenkins CW, Head IM, Stephens RC, et al. Decreased heart rate variability in patients with cirrhosis relates to the presence and severity of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2008;296:G330\u2013G338","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10590_CR114","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1478-3231.2009.02125.x","volume":"30","author":"S Genovesi","year":"2009","unstructured":"Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Vincenti A, et al. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient. Liver Int. 2009;30:232\u2013239","journal-title":"Liver Int"},{"key":"10590_CR115","doi-asserted-by":"crossref","first-page":"G1228","DOI":"10.1152\/ajpgi.00303.2012","volume":"303","author":"S M\u00f8ller","year":"2012","unstructured":"M\u00f8ller S, Mortensen C, Bendtsen F, Jensen LT, Gotze JP, Madsen JL. Cardiac sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to autonomic and cardiac function. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1228\u2013G1235","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10590_CR116","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/apt.15365","volume":"50","author":"C Jansen","year":"2019","unstructured":"Jansen C, Chatterjee DA, Thomsen KL, Al-Kassou B, Sawhney R, Jones H, et al. Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality. Aliment Pharmacol Ther. 2019;50:568\u2013579","journal-title":"Aliment Pharmacol Ther"},{"key":"10590_CR117","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1572-0241.2005.41060.x","volume":"100","author":"M Pozzi","year":"2005","unstructured":"Pozzi M, Grassi G, Ratti L, Favini G, Dell\u2019Oro R, Redaelli E, et al. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis. Am J Gastroenterol. 2005;100:1110\u20131116","journal-title":"Am J Gastroenterol"},{"key":"10590_CR118","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2010.06.040","volume":"160","author":"D Daneshvar","year":"2010","unstructured":"Daneshvar D, Wei J, Tolstrup K, Thomson LE, Shufelt C, Merz CN. Diastolic dysfunction: improved understanding using emerging imaging techniques. Am Heart J. 2010;160:394\u2013404","journal-title":"Am Heart J"},{"key":"10590_CR119","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-925X-10-76","volume":"10","author":"JS Lawton","year":"2011","unstructured":"Lawton JS, Cupps BP, Knutsen AK, Ma N, Brady BD, Reynolds LM, et al. Magnetic resonance imaging detects significant sex differences in human myocardial strain. Biomed Eng Online. 2011;10:76","journal-title":"Biomed Eng Online"},{"key":"10590_CR120","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1016\/S0168-8278(09)60757-1","volume":"50","author":"A Krag","year":"2009","unstructured":"Krag A, Bendtsen F, Kjaer A, Leth-Petersen C, M\u00f8ller S. Cardiac function studied by dobutamin stress MRI in patients with mild cirrhosis. J Hepatol. 2009;50:S277","journal-title":"J Hepatol"},{"key":"10590_CR121","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1532-429X-12-47","volume":"12","author":"D Lossnitzer","year":"2010","unstructured":"Lossnitzer D, Steen H, Zahn A, Lehrke S, Weiss C, Weiss KH, et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis. J Cardiovasc Magn Reson. 2010;12:47","journal-title":"J Cardiovasc Magn Reson"},{"key":"10590_CR122","first-page":"S49","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49\u2013S73","journal-title":"Circulation"},{"key":"10590_CR123","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/lt.21540","volume":"14","author":"NC McAvoy","year":"2008","unstructured":"McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl. 2008;14:1725\u20131731","journal-title":"Liver Transpl"},{"key":"10590_CR124","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/eci.12777","volume":"47","author":"K Kazankov","year":"2017","unstructured":"Kazankov K, Munk K, Ovrehus KA, Jensen JM, Siggaard CB, Gronbaek H, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Invest. 2017;47:565\u2013573","journal-title":"Eur J Clin Invest"},{"key":"10590_CR125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/liv.14092","volume":"10","author":"SS Patel","year":"2019","unstructured":"Patel SS, Lin FP, Rodriguez VA, Bhati C, John BV, Pence T, et al. The relationship between coronary artery disease and cardiovascular events early after liver transplantation. Liver Int. 2019;10:1363\u20131371","journal-title":"Liver Int"},{"key":"10590_CR126","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10620-018-5006-7","volume":"63","author":"KV Danielsen","year":"2018","unstructured":"Danielsen KV, Wiese S, Hove J, Bendtsen F, M\u00f8ller S. Pronounced coronary arteriosclerosis in cirrhosis: Influence on cardiac function and survival? Dig Dis Sci. 2018;63:1355\u20131362","journal-title":"Dig Dis Sci"},{"key":"10590_CR127","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12350-021-02552-7","volume":"28","author":"TM Bateman","year":"2021","unstructured":"Bateman TM, Heller GV, Beanlands R, Calnon DA, Case J, deKemp R, et al. Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Cardiol. 2021;28:768\u2013787","journal-title":"J Nucl Cardiol"},{"key":"10590_CR128","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.1840080337","volume":"8","author":"H Keller","year":"1988","unstructured":"Keller H, Bezjak V, Stegaru B, Buss J, Holm E, Heene DL. Ventricular function in cirrhosis and portasystemic shunt: a two-dimensional echocardiographic study. Hepatology. 1988;8:658\u2013662","journal-title":"Hepatology"},{"key":"10590_CR129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5114\/ceh.2021.108708","volume":"7","author":"M Cesari","year":"2021","unstructured":"Cesari M, Frigo AC, Piano S, Angeli P. Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification. Clin Exp Hepatol. 2021;7:270\u2013277","journal-title":"Clin Exp Hepatol"},{"key":"10590_CR130","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/lt.26504","volume":"28","author":"S M\u00f8ller","year":"2022","unstructured":"M\u00f8ller S, Hove JD. Cirrhotic cardiomyopathy: Toward an optimized definition. Liver Transpl. 2022;28:1283\u20131284","journal-title":"Liver Transpl"},{"key":"10590_CR131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u2013357","journal-title":"Hepatology"},{"key":"10590_CR132","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","volume":"73","author":"EM Brunt","year":"2021","unstructured":"Brunt EM, Kleiner DE, Carpenter DH, Rinella M, Harrison SA, Loomba R, et al. NAFLD: reporting histologic findings in clinical practice. Hepatology. 2021;73:2028\u20132038","journal-title":"Hepatology"},{"key":"10590_CR133","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","volume":"71","author":"ME Rinella","year":"2019","unstructured":"Rinella ME, Tacke F, Sanyal AJ, Anstee QM. Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD. J Hepatol. 2019;71:823\u2013833","journal-title":"J Hepatol"},{"key":"10590_CR134","doi-asserted-by":"crossref","first-page":"979","DOI":"10.14218\/JCTH.2021.00593","volume":"10","author":"SHH Nababan","year":"2022","unstructured":"Nababan SHH, Lesmana CRA. Portal hypertension in nonalcoholic fatty liver disease: from pathogenesis to clinical practice. J Clin Transl Hepatol. 2022;10:979\u2013985","journal-title":"J Clin Transl Hepatol"},{"issue":"Suppl 2","key":"10590_CR135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/dom.14484","volume":"24","author":"CD Byrne","year":"2022","unstructured":"Byrne CD, Targher G. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes Obes Metab. 2022;24(Suppl 2):28\u201343","journal-title":"Diabetes Obes Metab"},{"key":"10590_CR136","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42:e168\u2013e185","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10590_CR137","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.32519","volume":"76","author":"Y Shang","year":"2022","unstructured":"Shang Y, Nasr P, Widman L, Hagstr\u00f6m H. Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology. 2022;76:1495\u20131505","journal-title":"Hepatology"},{"key":"10590_CR138","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589\u2013600","journal-title":"J Hepatol"},{"key":"10590_CR139","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","volume":"2","author":"YY Zhou","year":"2018","unstructured":"Zhou YY, Zhou XD, Wu SJ, Fan DH, Van Poucke S, Chen YP, et al. Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis. Hepatol Commun. 2018;2:376\u2013392","journal-title":"Hepatol Commun"},{"key":"10590_CR140","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2018.01.023","volume":"68","author":"LB Vanwagner","year":"2018","unstructured":"Vanwagner LB. New insights into NAFLD and subclinical coronary atherosclerosis. J Hepatol. 2018;68:890\u2013892","journal-title":"J Hepatol"},{"key":"10590_CR141","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","volume":"53","author":"G Targher","year":"2010","unstructured":"Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol. 2010;53:713\u2013718","journal-title":"J Hepatol"},{"key":"10590_CR142","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/dom.14484","volume":"24","author":"CD Byrne","year":"2021","unstructured":"Byrne CD, Targher G. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes Obes Metab. 2021;24:28\u201343","journal-title":"Diabetes Obes Metab"},{"key":"10590_CR143","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","volume":"10","author":"LB Vanwagner","year":"2015","unstructured":"Vanwagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015;10:773\u2013783","journal-title":"Hepatology"},{"key":"10590_CR144","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","volume":"68","author":"Y Chang","year":"2019","unstructured":"Chang Y, Ryu S, Sung KC, Cho YK, Sung E, Kim HN, et al. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut. 2019;68:1667\u20131675","journal-title":"Gut"},{"key":"10590_CR145","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","volume":"291","author":"R Lautamaki","year":"2006","unstructured":"Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2006;291:E282\u2013E290","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10590_CR146","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2010.01.049","volume":"211","author":"Y Yilmaz","year":"2010","unstructured":"Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis. 2010;211:182\u2013186","journal-title":"Atherosclerosis"},{"key":"10590_CR147","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C Soderberg","year":"2010","unstructured":"Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51:595\u2013602","journal-title":"Hepatology"},{"key":"10590_CR148","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547\u20131554","journal-title":"Hepatology"},{"key":"10590_CR149","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","volume":"18","author":"F Baratta","year":"2019","unstructured":"Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, et al. Nonalcoholic fatty liver disease and fibrosis associated with Increased risk of cardiovascular events in a prospective study. Clin Gastroenterol Hepatol. 2019;18:2324\u2013233110","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10590_CR150","doi-asserted-by":"crossref","first-page":"e001979","DOI":"10.1161\/CIRCIMAGING.114.001979","volume":"8","author":"M Gran\u00e9r","year":"2014","unstructured":"Gran\u00e9r M, Nyman K, Siren R, Pentik\u00e4inen MO, Lundbom J, Hakkarainen A, Lauerma K, et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imag 2014;8(1):e001979","journal-title":"Circ Cardiovasc Imag"},{"key":"10590_CR151","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","volume":"62","author":"S Petta","year":"2015","unstructured":"Petta S, Argano C, Colomba D, Camma C, Di MV, Cabibi D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol. 2015;62:928\u2013933","journal-title":"J Hepatol"},{"key":"10590_CR152","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/hep.32072","volume":"74","author":"J Zhou","year":"2021","unstructured":"Zhou J, Bai L, Zhang XJ, Li H, Cai J. Nonalcoholic fatty liver disease and cardiac remodeling risk: pathophysiological mechanisms and clinical implications. Hepatology. 2021;74:2839\u20132847","journal-title":"Hepatology"},{"key":"10590_CR153","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","volume":"25","author":"TG Simon","year":"2017","unstructured":"Simon TG, Bamira DG, Chung RT, Weiner RB, Corey KE. Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction. Obesity (Silver Spring). 2017;25:1313\u20131316","journal-title":"Obesity (Silver Spring)"},{"key":"10590_CR154","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","volume":"50","author":"K Wijarnpreecha","year":"2018","unstructured":"Wijarnpreecha K, Lou S, Panjawatanan P, Cheungpasitporn W, Pungpapong S, Lukens FJ, et al. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Dig Liver Dis. 2018;50:1166\u20131175","journal-title":"Dig Liver Dis"},{"key":"10590_CR155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","volume":"272","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee JH, Lee H, Kim MK, Yim JY, Choi SY, et al. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. Atherosclerosis. 2018;272:137\u2013144","journal-title":"Atherosclerosis"},{"key":"10590_CR156","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","volume":"68","author":"YH Lee","year":"2018","unstructured":"Lee YH, Kim KJ, Yoo ME, Kim G, Yoon HJ, Jo K, et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol. 2018;68:764\u2013772","journal-title":"J Hepatol"},{"key":"10590_CR157","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/liv.14044","volume":"39","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dauriz M, Sandri D, Bonapace S, Zoppini G, Tilg H, et al. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. Liver Int. 2019;39:758\u2013769","journal-title":"Liver Int"},{"key":"10590_CR158","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14461","volume":"10","author":"X Cai","year":"2020","unstructured":"Cai X, Zheng S, Liu Y, Zhang Y, Lu J, Huang Y. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. Liver Int. 2020;10:1594\u20131600","journal-title":"Liver Int"},{"key":"10590_CR159","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/echo.14229","volume":"36","author":"RA Mahfouz","year":"2019","unstructured":"Mahfouz RA, Gouda M, Galal I, Ghareb MS. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation. Echocardiography. 2019;36:249\u2013256","journal-title":"Echocardiography"},{"key":"10590_CR160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185459","volume":"12","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Rigolon R, Pichiri I, Bonapace S, Morani G, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus. PLoS ONE. 2017;12: e0185459","journal-title":"PLoS ONE"},{"key":"10590_CR161","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","volume":"20","author":"S Ballestri","year":"2014","unstructured":"Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1724\u20131745","journal-title":"World J Gastroenterol"},{"key":"10590_CR162","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","volume":"24","author":"G Targher","year":"2014","unstructured":"Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Pichiri I, et al. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2014;24:663\u2013669","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10590_CR163","volume":"4","author":"CS Hung","year":"2015","unstructured":"Hung CS, Tseng PH, Tu CH, Chen CC, Liao WC, Lee YC, et al. Nonalcoholic fatty liver disease is associated with QT prolongation in the general poopulation. J Am Heart Assoc. 2015;4: e001820","journal-title":"J Am Heart Assoc"},{"key":"10590_CR164","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","volume":"39","author":"A Mantovani","year":"2016","unstructured":"Mantovani A, Rigamonti A, Bonapace S, Bolzan B, Pernigo M, Morani G, et al. Nonalcoholic fatty liver disease Is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring. Diabetes Care. 2016;39:1416\u20131423","journal-title":"Diabetes Care"},{"key":"10590_CR165","first-page":"661","volume":"33","author":"K Wijarnpreecha","year":"2020","unstructured":"Wijarnpreecha K, Panjawatanan P, Kroner PT, Cheungpasitporn W, Ungprasert P. Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Gastroenterol. 2020;33:661\u2013666","journal-title":"Ann Gastroenterol"},{"key":"10590_CR166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.1017","volume":"17","author":"EM Przybyszewski","year":"2021","unstructured":"Przybyszewski EM, Targher G, Roden M, Corey KE. Nonalcoholic fatty liver disease and cardiovascular disease. Clin Liver Dis (Hoboken). 2021;17:19\u201322","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10590_CR167","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:903\u2013913","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10590_CR168","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384","journal-title":"Hepatology"},{"key":"10590_CR169","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","volume":"11","author":"HT Mahfood","year":"2017","unstructured":"Mahfood HT, Hamdeh S, Kanmanthareddy A, Alla VM. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis. Diabetes Metab Syndr. 2017;11:S209\u2013S216","journal-title":"Diabetes Metab Syndr"},{"key":"10590_CR170","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijerph16173104","volume":"16","author":"C Tana","year":"2019","unstructured":"Tana C, Ballestri S, Ricci F, Di VA, Ticinesi A, Gallina S, et al. Cardiovascular risk in non-Alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 2019;16:3104","journal-title":"Int J Environ Res Public Health"},{"key":"10590_CR171","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun WV, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155:443\u2013457","journal-title":"Gastroenterology"},{"key":"10590_CR172","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apt.15660","volume":"51","author":"JB Henson","year":"2020","unstructured":"Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;51:728\u2013736","journal-title":"Aliment Pharmacol Ther"},{"key":"10590_CR173","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3748\/wjg.14.3445","volume":"14","author":"MS Mandell","year":"2008","unstructured":"Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M. Cardiac evaluation of liver transplant candidates. World J Gastroenterol. 2008;14:3445\u20133451","journal-title":"World J Gastroenterol"},{"key":"10590_CR174","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.metabol.2016.02.013","volume":"65","author":"RS Khan","year":"2016","unstructured":"Khan RS, Newsome PN. Non-alcoholic fatty liver disease and liver transplantation. Metabolism. 2016;65:1208\u20131223","journal-title":"Metabolism"},{"key":"10590_CR175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","volume":"98","author":"SD Tiukinhoy-Laing","year":"2006","unstructured":"Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178\u2013181","journal-title":"Am J Cardiol"},{"key":"10590_CR176","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","volume":"56","author":"LB Vanwagner","year":"2012","unstructured":"Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis (NASH) are at increased risk for post-operative cardiovascular events. Hepatology. 2012;56:1741\u20131750","journal-title":"Hepatology"},{"key":"10590_CR177","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1111\/ajt.17049","volume":"22","author":"M Izzy","year":"2022","unstructured":"Izzy M, Fortune BE, Serper M, Bhave N, deLemos A, Gallegos-Orozco JF, et al. Management of cardiac diseases in liver transplant recipients: comprehensive review and multidisciplinary practice-based recommendations. Am J Transplant. 2022;22:2740\u20132758","journal-title":"Am J Transplant"},{"key":"10590_CR178","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u2013460","journal-title":"J Hepatol"},{"key":"10590_CR179","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2010.11.003","volume":"54","author":"C Ripoll","year":"2010","unstructured":"Ripoll C, Yotti R, Bermejo J, Banares R. The heart in liver transplantation. J Hepatol. 2010;54:810\u2013822","journal-title":"J Hepatol"},{"key":"10590_CR180","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.amjcard.2012.08.021","volume":"110","author":"ME Harinstein","year":"2012","unstructured":"Harinstein ME, Iyer S, Mathier MA, Flaherty JD, Fontes P, Planinsic RM, et al. Role of baseline echocardiography in the preoperative management of liver transplant candidates. Am J Cardiol. 2012;110:1852\u20131855","journal-title":"Am J Cardiol"},{"key":"10590_CR181","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut. 2017;66:180\u2013190","journal-title":"Gut"},{"key":"10590_CR182","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66:1138\u20131153","journal-title":"Gut"},{"key":"10590_CR183","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2047487316653709","volume":"23","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1\u2013NP96","journal-title":"Eur J Prev Cardiol"},{"key":"10590_CR184","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","volume":"73","author":"DM Lloyd-Jones","year":"2019","unstructured":"Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC Jr, Sperling LS, Virani SS, et al. Use of risk assessment Ttols to \u201ca Guide\u201d decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the american heart association and american college of cardiology. J Am Coll Cardiol. 2019;73:3153\u20133167","journal-title":"J Am Coll Cardiol"},{"key":"10590_CR185","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1007\/s10620-022-07508-6","volume":"67","author":"H Kim","year":"2022","unstructured":"Kim H, Lee CJ, Ahn SH, Lee KS, Lee BK, Baik SJ, et al. MAFLD predicts the risk of cardiovascular disease better than NAFLD in asymptomatic subjects with health check-ups. Dig Dis Sci. 2022;67:4919\u20134928","journal-title":"Dig Dis Sci"},{"key":"10590_CR186","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apt.16305","volume":"53","author":"D Chahal","year":"2021","unstructured":"Chahal D, Liu H, Shamatutu C, Sidhu H, Lee SS, Marquez V. Review article: comprehensive analysis of cirrhotic cardiomyopathy. Aliment Pharmacol Ther. 2021;53:985\u2013998","journal-title":"Aliment Pharmacol Ther"},{"key":"10590_CR187","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/lt.26495","volume":"28","author":"M Izzy","year":"2022","unstructured":"Izzy M, DuBrock HM. CAQ Corner: Cardiovascular and pulmonary evaluation of liver transplantation candidates: what you need to know for the board exam. Liver Transpl. 2022;28:1529\u20131538","journal-title":"Liver Transpl"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10590-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T09:49:34Z","timestamp":1730195374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10590-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":187,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10590"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10590-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have not disclosed any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}